Background & aims: The biological role of fatty acids (FA) in the perinatal period is under active investigation. We here describe the application of a simplified microanalytical procedure to compare the FA profile of maternal, umbilical cord and infant whole blood, inclusive of all circulating lipid fractions and cells. Methods: The FA composition has been analyzed with a micromethod in 16 triplets, including maternal blood, cord blood at delivery and infant blood at day 4, respectively. Results: As expected, the FA composition of blood samples withdrawn from the umbilical cord is more similar to the FA composition of blood from 4-day old infants than the FA pattern of maternal blood at delivery. Nevertheless, infant blood FA profile differed from cord for lower long-chain polyunsaturated FA and higher monounsaturated FA. Conclusions: Our explorative data using whole blood microanalysis confirm the progressive increase of long-chain polyunsaturated FA levels from the mothers towards cord and then infant blood.
Introduction
The relevance of the essential polyunsaturated essential fatty acids (PUFA), i.e. linoleic acid (LA, 18:2 n-6) and alpha linolenic acid (ALA, 18:3 n-3), and of their long-chain polyunsaturated fatty acid (LC-PUFA) derivatives for the structural and functional development of brain cortex and retina has been supported by a lot of data. 1 The amounts of arachidonic (AA, 20:4 n-6) and docosahexaenoic (DHA, 22:6 n-3) acids supplied to the foetus by the mother throughout pregnancy are strictly dependent on maternal dietary intakes and metabolic processes taking place between the maternal and infant compartments, respectively, at the placenta level. Although the mechanisms at the cellular level are not fully elucidated yet, the knowledge of the inter-relationships between these compartments could be improved by the availability of analytical methods for the assessment of the FA pattern in large population groups. Finally, even if the composition of cord lipids has been repeatedly analysed, 2 few studies have explored the relationships between maternal/cord FA and the FA composition of infant blood lipid classes, for either ethical and practical reasons. We here describe the application of a simplified microanalytical procedure to compare the FA profile of maternal, umbilical cord and infant whole blood, as representative of all circulating lipid fractions and cells.
Methods
Sixteen healthy pregnant women aged 34 years (range 28e40), who delivered healthy term infants (38.5 weeks, range 37.5e39.3), with a weight appropriate for gestational age were recruited in our maternity ward. Exclusion criteria included alcohol consumption and smoking habits in order to avoid possible effects on the FA status. All mothers signed written informed consent for the three blood sampling procedures. The study had been previously approved by the Local Committee on Ethics.
Cord venous blood drops were collected immediately after infant delivery and after clamping of the cord. Maternal blood drops were withdrawn through the puncture of a fingertip, performed with an automatic lancing device equipped with lancets. Infant blood samples were collected from a heel prick at the same time of the Guthrie neonatal screening test on day 4 of life. All the infants were breast-fed, and didn't receive any supplemental formula.
All the samples were adsorbed on strips of chromatography paper, following an innovative method validated for reproducibility 3 and comparison with plasma and cell FA profiles, 4 and already applied to studies in adults 5 and infants. 6, 7 All the samples were directly subjected to transmethylation for gaschromatographic analysis using DANI GC 1000 equipped with an Omegawax TM 320 capillary column (30 m, ID 0.32 mm, df 0.25 mm) and FID as detector. FA were recognized by the use of reference standards and values were expressed as FA weight percentages. The SPSS package 16.0 for Windows (SPSS, Chicago, IL) was used for the statistical analyses. Data (expressed as median, minimum and maximum) were compared with non-parametric tests for 3 related samples (Friedman test) and post-hoc analysis with Dunn's test. Inter-relationships between FA were investigated with the non-parametric Spearman's r.
Results
Infant characteristics at birth (median and range) were as follows: weight 3.250 (2.760e4.010) gr, length 50 (47e54) cm and head circumference 34 (33e36) cm. The FA composition of whole blood in the three analysed compartments is reported in Table 1 .
As expected, the FA composition of blood samples withdrawn from the umbilical cord is more similar to the FA composition of blood from 4-day old infants than the FA pattern of maternal blood at delivery. Nevertheless, differences between infant and cord blood FA composition are present, with lower LC-PUFA and higher monounsaturated FA. Di-homo-gamma linolenic acid (DHGLA, 20:3 n-6), AA and DHA levels in blood from cord are higher, but in the same order of magnitude than in infant's samples, and are around 2-folds higher than in maternal blood. Conversely, the levels of LA and ALA are 3-to 4-folds lower in cord and infant blood, compared to mothers.
Considering the main product/precursor ratios, representative of the different metabolic steps involved in LC-PUFA biosynthesis of the two metabolic series, regulated by desaturase and elongase reactions, the ratios of the two main products (AA and DHA) with their 18 carbon precursors (LA and ALA, respectively) are similar in cord and infant blood. Nevertheless, considering the ratios of AA and DHA with the major intermediates (DHGLA and eicosapentaeoic acid, EPA, 20:5 n-3, respectively), the AA/DHGLA ratio (on the n-6 pathway) is higher in infant blood while the DHA/EPA ratio (on the n-3 pathway) is higher in cord blood.
Mutual inter-relationships have been also investigated for LA, ALA, AA, EPA and DHA values for maternal vs cord, maternal vs neonatal, and cord vs neonatal values, respectively. As concerns maternal vs cord values significant relationships have been found for LA (r ¼ 0.575, P ¼ 0.020) and EPA (r ¼ 0.673, P ¼ 0.004), while as far as cord vs neonatal percentage concentrations, a significant correlation has been found only for LA (r ¼ 0.526, P ¼ 0.036). No other relations between the levels of the same fatty acid and the three compartments have been found.
Discussion
To our knowledge, this is the first study investigating the FA composition of whole blood in triplets of mothers, cord and infants. Other previous studies have considered the relationship between the maternal compartments and the infants by analysing plasma total lipids or phospholipids or red blood cells. However whole blood lipids are representative of the FA composition of all the circulating lipid classes, lipoproteins and cells. Our observations confirm previous observations with different methodology on the progressively higher levels of LC-PUFA from mothers towards cord and infants, respectively. 8 In this context, the infant FA profile only marginally reflects the maternal FA status, partly depending on the maternal release and partly upon the metabolism in the placenta or the infant. The biomechanisms at the basis of these differences are actually under active investigation. In spite of the documented LC-PUFA biosynthesis in both preterm and term newborns, 9 the two major LC-PUFA (AA and DHA) in whole blood are already decreased at four days of life compared to cord levels Consumption and/or utilization rates higher than synthetic capacities of infants might explain these observations. Of interest, maternal n-3 LC-PUFA levels (including both EPA and DHA) are related to the n-3 LC-PUFA levels of cord but not of infants. We conclude that, consistent with the explorative purposes of our study, the micro invasive and microanalytical method for the whole blood FA analysis seems to be a useful tool to obtain further information concerning fatty acids from larger populations and elucidate the mechanisms regulating the transfer/distribution of PUFA within the maternal-infant dyad.
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